Sunday, 13 August 2017

Primer on CAR T-cell therapy for GBM

This is a useful overview of CAR (chimeric antigen receptor) T-cell therapy and its application to GBM published a few days ago at CancerCommons, written by their chief scientist.

Reengineering Immune System Cells to Fight Glioblastoma (click on link)


  1. Hi Stephen,

    We are very interested in DCVax-L treatment. We heard a few months ago that it may open to the public treatment in U.K through their special program but never have chance to learn the update. Do you have some news about it? Or any opinion about DCVax-L would be helpful.

    Your reply would be great appreciated.


    1. Hi Luyeza,
      I can't help you with any info on the UK program, but I just made a new post about the DCVax presentation given a couple months ago at ASCO.

    2. Thanks for letting me know.